PPA
ORGO icon

Parametric Portfolio Associates’s Organogenesis Holdings ORGO Stock Holding History

Parametric Portfolio Associates’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.03M Sell
135,077
-84,482
-38% -$654K ﹤0.01% 2773
2021
Q4 		$2.03M Buy
219,559
+32,148
+17% +$341K ﹤0.01% 2431
2021
Q3 		$2.67M Sell
187,411
-65,463
-26% -$1.02M ﹤0.01% 2255
2021
Q2 		$4.2M Buy
252,874
+7,318
+3% +$136K ﹤0.01% 1960
2021
Q1 		$4.47M Buy
245,556
+229,458
+1,425% +$3.11M ﹤0.01% 2260
2020
Q4 		$121K Buy
16,098
+968
+6% +$4.6K ﹤0.01% 3866
2020
Q3 		$58K Buy
+15,130
New +$59.7K ﹤0.01% 3853
2018
Q4 		– Sell
-95,000
Closed -$962K – 3942
2018
Q3 		$962K Buy
95,000
+8,000
+9% +$80.7K ﹤0.01% 3121
2018
Q2 		$873K Buy
87,000
+69,000
+383% +$691K ﹤0.01% 3121
2018
Q1 		$180K Buy
+18,000
New +$179K ﹤0.01% 3784

Other funds holding ORGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's ORGO Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Organogenesis Holdings (ORGO) stake by 38% in Q1 2022, selling an estimated $654K and leaving 135,077 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Parametric Portfolio Associates first reported a position in ORGO in Q1 2018 and has held it in 10 quarters since. The position peaked at $4.47M in Q1 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

  • Parametric Portfolio Associates held 135,077 shares of Organogenesis Holdings worth $1.03M as of Q1 2022.
  • Parametric Portfolio Associates sold 84,482 Organogenesis Holdings shares in Q1 2022, an estimated $654K.
  • Organogenesis Holdings made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2773 holding.
  • Parametric Portfolio Associates first reported a position in Organogenesis Holdings in Q1 2018 and has held it in 10 quarters since.
  • Parametric Portfolio Associates's Organogenesis Holdings position peaked at $4.47M in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.